Clinical trials have adapted quickly to the virtual world by necessity, and clinical teams are experimenting with new methods of virtual meetings, remote training, and study start-up. In this webinar, we review and examine the success and pitfalls of
remote training solutions and global access to digital resources, as well as proven methods to increase attention and engagement for virtual teams. Join this webinar to learn from experienced pharmaceutical leaders on how solutions can be optimized
for remote trials, and how their lessons can improve all Investigator Meetings (IMs), Site Initiation Visits (SIVs), and clinical training.
- How to effectively manage virtual IMs and SIVs
- What challenges have virtual IMs and SIVs posed to clinical teams and site staff?
- How can globally distributed sites maintain access to the right resources and training throughout the study?
- Align goals: ensure that IMs and SIVs are designed to benefit diverse stakeholders (sponsors, investigators, CROs, and site staff) and ensure compliant teams
This webinar will benefit professionals working in:
- Clinical Operations
- Clinical Development
- Clinical Research
- Clinical Project Management
- Clinical Trial Managers
- Clinical Research
- Medical Affairs
Mark Surles, PhD
Dr. Surles brings 20 years of experience leading software and content companies in the life science market. He was Founder and CEO of Interactive Simulations, which led the migration of 3D graphics to medicinal chemists, and led product marketing
and strategy at Elsevier, the leader in scientific publishing. He also has executive experience in medical device, informatics, and healthcare patent management. He holds a Ph.D. in Computer Science from the University of North Carolina at Chapel
Archana Sah, MS Pharm., PMP
Vice President, Head of Clinical Development Operations, Tizona Therapeutics, Inc.; Oncology Board Chair, Society for Clinical Research Sites (SCRS)
Archana Sah is an innovative and collaborative clinical development thought leader with 22+ years experience and a passion for developing medicines for patients, having led and contributed to 15 FDA/EMEA drug approvals in Oncology, Immuno-Oncology,
Precision Therapeutics, Rare Diseases, Metabolic Diseases, and Women’s Health. She has held various global positions within Biotech, Big Pharma, and Oncology startup companies and in the last five years, she has led/contributed to 10 drugs
from research to approvals in the Oncology and Immuno-Oncology space at Genentech/Roche. She recently joined Tizona Therapeutics, a company focused on improving outcomes for cancer patients by translating novel scientific insights into developing
first-in-class immunotherapies. Ms. Sah also chairs the Society for Clinical Research Sites (SCRS) Oncology Board with a vision to cure cancer through efficiency in process and strength in the relationships between clinical research sites, pharmaceutical
companies, and patients. SCRS represents the voice of more than 10,000 investigators and sites across 47 countries. Ms. Sah also serves as a member of the American Cancer Society Cancer Action Network workstreams on Barriers to Clinical Trial
Enrollment Implementation and Clinical Trial Matching.
Executive Director, Site Account Management and Site Monitoring, ESD CRD, Global Clinical Trial Operations, Merck Research Laboratories
Jane Hiatt joined Merck in 1999 and is currently the Executive Director Site Management and Monitoring, Early Stage Development. She is responsible for the monitoring organization across a diverse portfolio and the clinical trial execution within
the Phase 1 Portfolio. Jane's background includes over 30 years of drug experience in CRO and large pharma environments starting in data management followed by progressive roles in clinical trial operations and management.
For over 25 years, ScienceMedia has been at the forefront of delivering innovative, multimedia learning solutions aimed at improving clinical competency across all functional areas in the world's leading life sciences organizations. ScienceMedia draws on its expert team of clinical writers, instructional designers, and multimedia artists to produce impactful training on the highest risk areas of a clinical trial. SMi Trial mitigates clinical risk and decreases trial cost by optimizing study compliance throughout the lifetime of your clinical trial. SMi Source is a mobile-enabled, cloud-based science education library that provides 16,000+ microlearning topics and 400+ full courses covering a vast catalog of disease and therapeutic areas. Discover more at www.sciencemedia.com.